Rezultati pretrage - Viktrup, Lars
- Prikaz rezultata 1 – 20 od 26
- Idi na sljedeću stranicu
-
1
-
2
-
3
-
4
-
5
Construct validation of patient global impression of severity (PGI-S) and improvement (PGI-I) questionnaires in the treatment of men with lower urinary tract symptoms secondary to... od Viktrup, Lars, Hayes, Risa P, Wang, Ping, Shen, Wei
Izdano 2012Tekst -
6
-
7
-
8
Tadalafil for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a review of clinical data in Asian men and an update on the mechanism of action od Yokoyama, Osamu, Igawa, Yasuhiko, Takeda, Masayuki, Yamaguchi, Takafumi, Murakami, Masahiro, Viktrup, Lars
Izdano 2015Tekst -
9
-
10
-
11
Nerve growth factor antibody for the treatment of osteoarthritis pain and chronic low-back pain: mechanism of action in the context of efficacy and safety od Schmelz, Martin, Mantyh, Patrick, Malfait, Anne-Marie, Farrar, John, Yaksh, Tony, Tive, Leslie, Viktrup, Lars
Izdano 2019Tekst -
12
The Efficacy and Safety of Tadalafil 5 mg Once Daily in Korean Men with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia: An Integrated Analysis od Lee, Sung Won, Paick, Jae Seung, Park, Hyun Jun, Won, Ji Eon, Morisaki, Yoji, Sorsaburu, Sebastian, Viktrup, Lars
Izdano 2014Tekst -
13
Gender, age, disease severity, body mass index and diabetes may not affect response to subcutaneous tanezumab in patients with osteoarthritis after 16 weeks of treatment. A subgrou... od Berenbaum, Francis, Schnitzer, Thomas, Kivitz, Alan, Viktrup, Lars, Johnston, Elizabeth, Yang, Ruoyong, Whalen, Ed, Tive, Leslie, Semel, David
Izdano 2021Tekst -
14
General Safety and Tolerability of Subcutaneous Tanezumab for Osteoarthritis: A Pooled Analysis of Three Randomized, Placebo‐Controlled Trials od Berenbaum, Francis, Schnitzer, Thomas J., Kivitz, Alan J., Viktrup, Lars, Hickman, Anne, Pixton, Glenn, Brown, Mark T., Davignon, Isabelle, West, Christine R.
Izdano 2022Tekst -
15
Multimodal Treatment Patterns for Osteoarthritis and Their Relationship to Patient-Reported Pain Severity: A Cross-Sectional Survey in the United States od Nalamachu, Srinivas R, Robinson, Rebecca L, Viktrup, Lars, Cappelleri, Joseph C, Bushmakin, Andrew G, Tive, Leslie, Mellor, Jennifer, Hatchell, Niall, Jackson, James
Izdano 2020Tekst -
16
Burden of chronic low back pain: Association with pain severity and prescription medication use in five large European countries od Perrot, Serge, Doane, Michael J., Jaffe, Dena H., Dragon, Erika, Abraham, Lucy, Viktrup, Lars, Bushmakin, Andrew G., Cappelleri, Joseph C., Conaghan, Philip G.
Izdano 2021Tekst -
17
Effect of Tanezumab on Joint Pain, Physical Function, and Patient Global Assessment of Osteoarthritis Among Patients With Osteoarthritis of the Hip or Knee: A Randomized Clinical T... od Schnitzer, Thomas J., Easton, Richard, Pang, Shirley, Levinson, Dennis J., Pixton, Glenn, Viktrup, Lars, Davignon, Isabelle, Brown, Mark T., West, Christine R., Verburg, Kenneth M.
Izdano 2019Tekst -
18
Satisfaction with Medications Prescribed for Osteoarthritis: A Cross-Sectional Survey of Patients and Their Physicians in the United States od Robinson, Rebecca L., Schnitzer, Thomas J., Barlow, Sophie, Berry, Mia, Bushmakin, Andrew G., Cappelleri, Joseph C., Tive, Leslie, Jackson, Jessica, Jackson, James, Viktrup, Lars
Izdano 2022Tekst -
19
Factors associated with physician-reported treatment status of patients with osteoarthritis pain od Schnitzer, Thomas J., Robinson, Rebecca L., Tive, Leslie, Cappelleri, Joseph C., Bushmakin, Andrew G., Jackson, James, Berry, Mia, Barlow, Sophie, Walker, Chloe, Viktrup, Lars
Izdano 2022Tekst -
20
Subcutaneous tanezumab for osteoarthritis of the hip or knee: efficacy and safety results from a 24-week randomised phase III study with a 24-week follow-up period od Berenbaum, Francis, Blanco, Francisco J, Guermazi, Ali, Miki, Kenji, Yamabe, Takaharu, Viktrup, Lars, Junor, Rod, Carey, William, Brown, Mark T, West, Christine R, Verburg, Kenneth M
Izdano 2020Tekst